Peter Wiedemann Selected Research

Kcnj10 (channel)

5/2009	Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat.
8/2004	A potassium channel-linked mechanism of glial cell swelling in the postischemic retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Wiedemann Research Topics

Disease

28	Hypoxia (Hypoxemia) 01/2022 - 07/2004
21	Macular Degeneration (Age-Related Maculopathy) 08/2021 - 02/2005
20	Ischemia 01/2021 - 08/2004
17	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2021 - 08/2004
15	Edema (Dropsy) 01/2015 - 09/2004
15	Gliosis 01/2014 - 02/2002
14	Retinal Detachment (Retinal Detachments) 01/2021 - 05/2003
12	Proliferative Vitreoretinopathy 10/2022 - 03/2002
12	Choroidal Neovascularization 07/2021 - 05/2004
11	Inflammation (Inflammations) 01/2019 - 04/2005
10	Retinal Diseases 01/2022 - 08/2004
10	Hypertension (High Blood Pressure) 01/2019 - 01/2015
10	Retinal Vein Occlusion 11/2017 - 05/2008
10	Ganglion Cysts (Ganglion) 01/2015 - 11/2004
9	Macular Edema 04/2020 - 09/2004
8	Epiretinal Membrane (Epiretinal Membranes) 01/2021 - 08/2004
6	Papilledema 10/2016 - 07/2006
5	Necrosis 01/2020 - 03/2005
5	Neoplasms (Cancer) 01/2014 - 03/2005
4	Wounds and Injuries (Trauma) 04/2021 - 07/2009
4	Cataract (Cataracts) 01/2020 - 01/2015
4	Mitochondrial Diseases (Mitochondrial Disease) 07/2016 - 01/2011
4	Type 2 Diabetes Mellitus (MODY) 08/2015 - 11/2010
4	Pathologic Neovascularization 09/2014 - 10/2006
4	Hypertrophy 08/2008 - 08/2005
4	Retinal Neovascularization 04/2007 - 08/2004
3	Retinal Perforations 01/2021 - 01/2019
3	Retinal Degeneration 08/2019 - 08/2005
3	Hyperglycemia 12/2016 - 03/2006
3	Eye Diseases (Eye Disease) 01/2013 - 10/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
2	Vision Disorders (Hemeralopia) 01/2020 - 05/2018
2	Blindness (Hysterical Blindness) 01/2020 - 06/2005
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 01/2011
2	Intraoperative Complications 01/2017 - 01/2016
2	Phototoxic Dermatitis (Phototoxicity) 01/2014 - 07/2010
2	Myopia 01/2013 - 08/2005
2	Melanoma (Melanoma, Malignant) 06/2012 - 12/2003

Drug/Important Bio-Agent (IBA)

81	Retinaldehyde (Retinal)IBA 04/2021 - 05/2003
30	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 07/2004
12	Proteins (Proteins, Gene)FDA Link 12/2018 - 05/2003
10	SaltsIBA 01/2019 - 01/2015
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2016 - 12/2003
7	Retinal Pigments (Pigments, Visual)IBA 01/2022 - 08/2002
7	CytokinesIBA 01/2016 - 07/2004
7	Aquaporins (Water Channels)IBA 01/2015 - 08/2004
7	Glial Fibrillary Acidic ProteinIBA 01/2013 - 08/2004
7	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 08/2011 - 07/2005
6	Messenger RNA (mRNA)IBA 01/2022 - 03/2006
6	Ranibizumab (Lucentis)FDA Link 07/2021 - 05/2011
5	VimentinIBA 10/2012 - 05/2006
5	pigment epithelium-derived factorIBA 01/2012 - 01/2006
5	Glutamic Acid (Glutamate)FDA Link 01/2008 - 12/2003
4	Adenosine Triphosphate (ATP)IBA 07/2016 - 02/2002
4	SolutionsIBA 03/2016 - 09/2003
4	Epidermal Growth Factor (EGF)IBA 01/2016 - 06/2005
4	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2016 - 06/2005
4	Pharmaceutical PreparationsIBA 01/2013 - 02/2005
4	Triamcinolone (Aristocort)FDA Link 05/2007 - 07/2005
3	Heparin (Liquaemin)FDA LinkGeneric 10/2022 - 06/2005
3	afliberceptIBA 08/2021 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2011
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2018 - 07/2004
3	LipidsIBA 07/2016 - 02/2011
3	Transcription Factors (Transcription Factor)IBA 01/2015 - 04/2009
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2014 - 03/2005
3	AntioxidantsIBA 01/2013 - 07/2006
3	PotassiumIBA 01/2012 - 02/2008
3	Streptozocin (Streptozotocin)FDA Link 09/2011 - 10/2008
3	Phosphotransferases (Kinase)IBA 09/2011 - 12/2003
3	Matrix Metalloproteinases (MMPs)IBA 09/2007 - 01/2006
2	Sucrose (Saccharose)IBA 01/2022 - 12/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2020 - 09/2016
2	Purinergic Receptors (Receptors, Purine)IBA 12/2018 - 09/2011
2	InflammasomesIBA 12/2018 - 01/2016
2	Capsules (Microcapsules)IBA 01/2017 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 06/2012
2	EnzymesIBA 12/2016 - 01/2014
2	Vascular Endothelial Growth Factor BIBA 08/2016 - 08/2011
2	Photosensitizing Agents (Photosensitizers)IBA 01/2014 - 03/2005
2	A-Form DNA (A-DNA)IBA 01/2014 - 01/2013
2	Caspase 3 (Caspase-3)IBA 01/2014 - 12/2011
2	Thrombospondin 1IBA 01/2014 - 07/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2012 - 06/2006
2	ProstaglandinsIBA 08/2012 - 08/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2012 - 04/2009
2	cobaltous chloride (cobalt(II)chloride)IBA 08/2012 - 01/2012
2	Arachidonic Acid (Vitamin F)IBA 08/2012 - 12/2005
2	Carisoprodol (Soma)FDA LinkGeneric 06/2012 - 12/2005
2	Bevacizumab (Avastin)FDA Link 01/2012 - 12/2011
2	AntibodiesIBA 01/2012 - 10/2010

Therapy/Procedure

6	Lasers (Laser) 05/2018 - 04/2009
5	Traction 01/2021 - 02/2013
5	Vitrectomy 01/2020 - 06/2003
4	Photochemotherapy (Photodynamic Therapy) 01/2014 - 03/2005
4	Therapeutics 01/2014 - 11/2010
3	Intraocular Lens Implantation 01/2017 - 01/2015
2	Injections 08/2021 - 03/2021
2	Light Coagulation 10/2014 - 05/2014
2	Intravitreal Injections 09/2013 - 12/2011